ConductScience.org, home

Trial · NCT03112174

Results by group193

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Number of Participants With Tumor Lysis Syndrome (TLS) Events (Safety Run-in)Safety Run-in: Increased TLS Risk at Baseline1Participants
Number of Participants With Tumor Lysis Syndrome (TLS) Events (Safety Run-in)Safety Run-in: Low TLS Risk at Baseline0Participants
Number of Participants With Dose Limiting Toxicities (DLT) (Safety Run-in)Safety Run-in: Increased TLS Risk at BaselineAny TEAE/Any Grade3Participants
Number of Participants With Dose Limiting Toxicities (DLT) (Safety Run-in)Safety Run-in: Low TLS Risk at BaselineAny TEAE/Any Grade0Participants
Number of Participants With Dose Limiting Toxicities (DLT) (Safety Run-in)Safety Run-in: Increased TLS Risk at BaselineAny TEAE/ Grade 3+43Participants
Number of Participants With Dose Limiting Toxicities (DLT) (Safety Run-in)Safety Run-in: Low TLS Risk at BaselineAny TEAE/ Grade 3+40Participants
Number of Participants With Dose Limiting Toxicities (DLT) (Safety Run-in)Safety Run-in: Increased TLS Risk at BaselineAny TEAE/Grade 50Participants
Number of Participants With Dose Limiting Toxicities (DLT) (Safety Run-in)Safety Run-in: Low TLS Risk at BaselineAny TEAE/Grade 50Participants
Number of Participants With Dose Limiting Toxicities (DLT) (Safety Run-in)Safety Run-in: Increased TLS Risk at BaselineAtrial fibrillation/Any Grade1Participants
Number of Participants With Dose Limiting Toxicities (DLT) (Safety Run-in)Safety Run-in: Low TLS Risk at BaselineAtrial fibrillation/Any Grade0Participants
Number of Participants With Dose Limiting Toxicities (DLT) (Safety Run-in)Safety Run-in: Increased TLS Risk at BaselineAtrial fibrillation/Grade 3+41Participants
Number of Participants With Dose Limiting Toxicities (DLT) (Safety Run-in)Safety Run-in: Low TLS Risk at BaselineAtrial fibrillation/Grade 3+40Participants
Number of Participants With Dose Limiting Toxicities (DLT) (Safety Run-in)Safety Run-in: Increased TLS Risk at BaselineAtrial fibrillation/Grade 50Participants
Number of Participants With Dose Limiting Toxicities (DLT) (Safety Run-in)Safety Run-in: Low TLS Risk at BaselineAtrial fibrillation/Grade 50Participants
Number of Participants With Dose Limiting Toxicities (DLT) (Safety Run-in)Safety Run-in: Increased TLS Risk at BaselineInfection/Any Grade1Participants
Number of Participants With Dose Limiting Toxicities (DLT) (Safety Run-in)Safety Run-in: Low TLS Risk at BaselineInfection/Any Grade0Participants
Number of Participants With Dose Limiting Toxicities (DLT) (Safety Run-in)Safety Run-in: Increased TLS Risk at BaselineInfection/Grade 3+41Participants
Number of Participants With Dose Limiting Toxicities (DLT) (Safety Run-in)Safety Run-in: Low TLS Risk at BaselineInfection/Grade 3+40Participants
Number of Participants With Dose Limiting Toxicities (DLT) (Safety Run-in)Safety Run-in: Increased TLS Risk at BaselineInfection/Grade 50Participants
Number of Participants With Dose Limiting Toxicities (DLT) (Safety Run-in)Safety Run-in: Low TLS Risk at BaselineInfection/Grade 50Participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03112174/results